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ABSTRACT
Objective: Objective of the study was to synthesize and evaluate a series of novel compounds, ethyl 2-(2-cyano-3-(substituted phenyl)acrylamido)-
4,5-dimethylthiophene-3-carboxylates, for in vitro antioxidant and in vivo anti-inflammatory activities.
Methods: Ethyl 2-(2-cyano-3-(substituted phenyl)acrylamido)-4,5-dimethylthiophene-3-carboxylates were synthesized by knoevenagel condensation 
of active methylene group of ethyl 2-(2-cyanoacetamido)-4,5-dimethylthiophene-3-carboxylate with substituted benzaldehydes. The synthesized 
compounds were evaluated for their in vitro antioxidant properties in three different models, viz., reduction of 1,1-diphenyl-2-pycrylhydrazyl free 
radical, scavenging of nitric oxide free radical, and ferric ion-induced lipid peroxidation using rat brain homogenate. Few selected compounds with 
good antioxidant properties were pharmacologically evaluated for anti-inflammatory activity by carrageenan-induced rat paw edema model.
Results: Clean and efficient synthetic procedure was used for the preparation of series of compounds. The structures of synthesized compounds 
were confirmed by infrared, 1H nuclear magnetic resonance and mass spectra. The antioxidant activity data revealed that the compounds of ethyl 
2-(2-cyano-3-(substituted phenyl)acrylamido)-4,5-dimethylthiophene-3-carboxylate containing phenolic substitution showed greater antioxidant 
activity. Hence, the active compounds were evaluated for anti-inflammatory activity and found to possess good activity. The percentage inhibition of 
rat paw edema obtained for the evaluated compounds was in the range of 70.2-83.1, comparable to the standard drug diclofenac (85.0%).
Conclusion: The use of inexpensive, eco-friendly and readily available reagents, easy work-up and high purity of products makes the procedure a 
convenient and robust method for the synthesis of title compounds. The compounds of ethyl 2-(2-cyano-3-(substituted phenyl)acrylamido)-4,5-
dimethylthiophene-3-carboxylate containing phenolic substitution showed greater antioxidant and anti-inflammatory activities.
Keywords: 2-Aminothiophene, Cyanoacetamide, Knoevenagel condensation, 2-Cyano-3-(substituted phenyl)acrylamides.
INTRODUCTION
Thiophene is a five-membered sulfur-containing aromatic heterocyclic 
compound with the formula C4H4S. The name thiophene has been 
taken from the word theion, the Greek word for sulfur, and another 
Greek word phaino which means shining. Its structure can be found in 
certain natural products and incorporated in several pharmacologically 
active compounds [1]. Within this class of heterocyclic compounds, 
2-aminothiophene ring system and their substituted derivatives have 
attracted a great deal of interest over the years. These compounds 
were reported as phosphate PTP1B inhibitors [2], adenosine receptor 
A3 inhibitors [3], and serotonin receptor subtype 5-HT1A inhibitors [4]. 
They are also used as starting materials for the synthesis of dyes, 
agrochemicals and conducting polymers [5].
The substituted 2-aminothiophene ring system incorporated in several 
pharmacologically active compounds such as olanzapine, an antipsychotic 
drug and tinoridine, a potent nonsteroidal anti-inflammatory drug 
with antiperoxidative properties. Some of the molecules containing 
2-aminothiophene structure are under development as selective 
allosteric enhancer of adenosine A1 receptor, which includes T-62, 
PD81723 and ATL525 [6]. In our laboratory, ethyl 2-(2-cyanoacetamido)-
4,5-dimethylthiophene-3-carboxylate was synthesized from 2-amino-
4,5-dimethylthiophene-3-carboxylate by a versatile method and 
reported as good analgesic agent with antioxidant properties [7]. The 
synthesized compound has two nucleophilic sites, methylene group 
carbon and amide nitrogen, open wide synthetic opportunities for 
further reactions. The reactivity order of methylene carbon is greater 
than the amide nitrogen and can undergo knoevenagel condensation 
with substituted benzaldehydes to give 2-cyano-3-(substituted phenyl)
acrylamides. Further, various 2-cyano-3-(substituted phenyl)acrylamides 
were reported to possess diverse pharmacological activities, of which 
entacapone is now clinically used as antiparkinsonism drug [8-13].
In view of potential pharmacological activities of ethyl 
2-(2-cyanoacetamido)-4,5-dimethylthiophene-3-carboxylate and 
2-cyano-3-(substituted phenyl)acrylamides, it has been planned to 
synthesize a series of novel compounds, ethyl 2-(2-cyano-3-(substituted 
phenyl)acrylamido)-4,5-dimethylthiophene-3-carboxylates and to 
evaluate the synthesized compounds for the in vitro antioxidant and 
in vivo anti-inflammatory activities.
EXPERIMENTAL
Aldehydes procured from Sigma-Aldrich and SD fine chemicals. All 
other chemicals are of AR grade. Melting points were determined in 
open capillaries on a digital Stuart melting point apparatus and are 
uncorrected. Purity of the compounds was checked using the glass 
plates coated with Silica gel-G, and spots were detected by iodine vapor. 
The IR spectra recorded using KBr Pellets on a BRUKER infrared (IR) 
spectrophotometer (cm−1). 1H nuclear magnetic resonance (NMR) 
spectra recorded on Avance-400 MHz spectrometer using TMS as 
internal standard (chemical shifts in δ ppm) and mass spectra recorded 
on applied EI techniques on Shimadzu QP 2011 PLUS GC-MS system.
Animal experiments were carried out in accordance with the guidelines 
of CPCSEA and by the approval of the Institutional Animal Ethics 
Committee [Regd. No. 1677/PO/Re/2012/CPCSEA/26].
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i7.18290
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General procedure for synthesis of ethyl 2-(2-cyano-3-(substituted 
phenyl)acrylamido)-4,5-dimethylthiophene-3-carboxylates (Scheme 1, 
3a-3k):
Ethyl 2-(2-cyanoacetamido)-4,5-dimethylthiophene-3-carboxylate (10 
mmol) and substituted benzaldehydes (11 mmol) were added to 50 ml 
of toluene. To this mixture, 0.35 ml piperidine and 1.3 ml acetic acid 
were added and refluxed for 5-6 hrs. The completion of the reaction 
was monitored by performing thin-layer chromatography. Then, the 
reaction mixture was cooled to room temperature; the precipitate was 
separated by filtration and recrystallized with suitable solvent.
3a Ethyl 2-(2-cyano-3-phenylacrylamido)-4,5-dimethylthiophene-3-
carboxylate: mp. 230-232°C; yield 75%; IR (KBr) υmax: 3423 (N-H str), 
2987, 2930, 2861 (C-H str), 2214 (C≡N str), 1667 (ester C=O str), 1591 
(amide C=O str), 1561, 1530, 1446 (C=C str), 1261 (C-O str) cm−1; 1H 
NMR (CDCl3) δ: 1.40-1.43 (t, 3H, CH3), 2.29-2.31 (2s, 6H, CH3), 4.43-4.48 
(q, 2H, -CH2-), 7.70-7.78 (m, 5H, Ar), 8.30 (s, 1H, -CH=), 12.32(s, 1H, NH) 
ppm; Mass m/z: 377(M+ Na)+.
3b Ethyl 2-(2-cyano-3-(4-chlorophenyl)acrylamido)-4,5-
dimethylthiophene-3-carboxylate: mp. 227-228°C; yield 85%; IR (KBr) 
υmax: 3424 (N-H str), 2987, 2928, 2859 (C-H str), 2212 (C≡N str), 1667 
(ester C=O str), 1599 (amide C=O str), 1559, 1527, 1411 (C=C str), 1263 
(C-O str), 1096 (C-Cl str) cm−1; 1H NMR (CDCl3) δ: 1.39-1.43 (t, 3H, CH3), 
2.29-2.31 (2s, 6H, CH3), 4.43-4.48 (q, 2H, -CH2-), 7.49-7.51 and 7.93-
7.95(2d, 4H, Ar), 8.35 (s, 1H, -CH=), 12.35 (s, 1H, NH) ppm; Mass m/z: 
389 (M+).
3c Ethyl 2-(2-cyano-3-(4-methylphenyl)acrylamido)-4,5-dimethyl 
thiophene-3-carboxylate: mp. 232-235°C; yield 94%; IR (KBr) υmax: 3444 
(N-H str), 2989, 2924, 2858 (C-H str), 2213 (C≡N str), 1664 (ester C=O 
str), 1590 (amide C=O str), 1562, 1531, 1411 (C=C str), 1261(C-O str) 
cm−1; 1H NMR (CDCl3) δ: 1.40-1.43 (t, 3H, CH3), 2.29-2.30 (2s, 6H, CH3), 
2.44 (s, 3H, CH3), 4.43-4.48 (q, 2H, -CH2-), 7.31-7.33 and 7.90-7.92 (2d, 4H, 
Ar), 8.36 (s, 1H, -CH=), 12.27 (s, 1H, NH) ppm; Mass m/z: 391 (M+ Na)+.
3d Ethyl 2-(2-cyano-3-(4-hydroxyphenyl)acrylamido)-4,5-dimethyl 
thiophene-3-carboxylate: mp. 298-300°C; yield 90%; IR (KBr) υmax: 
3239 (N-H str), 3131 (O-H str), 2990, 2926 (C-H str), 2212 (C≡N str), 
1660 (ester C=O str), 1605 (amide C=O str), 1562, 1510, 1435 (C=C 
str), 1230 (C-O str) cm−1; 1H NMR (CDCl3) δ: 1.33-1.37 (t, 3H, CH3), 2.23-
2.26 (2s, 6H, CH3), 4.33-4.38 (q, 2H, -CH2-), 6.96-6.98 and7.98-8.01 (2d, 
4H, Ar), 8.29 (s, 1H, -CH=), 10.83 (s, 1H, OH), 11.87 (s, 1H, NH) ppm; 
Mass m/z: 369 (M-1).
3e Ethyl 2-(2-cyano-3-(4-hydroxy-3-methoxyphenyl)acrylamido)-
4,5-dimethyl thiophene-3-carboxylate: mp. 215-216°C; yield 88%; IR 
Scheme 1: Synthesis of ethyl 2-(2-cyano-3-(substituted phenyl)acrylamido)-4,5-dimethylthiophene-3-carboxylates
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(KBr) υmax: 3539 (N-H str), 3110 (O-H str), 2986, 2933, 2864 (C-H str), 
2211 (C≡N str), 1664 (ester C=O str), 1607 (amide C=O), 1565, 1512, 
1436 (C=C str), 1256 (C-O str), 1116 and 1028 (C-O-C asymmetric and 
symmetric) cm−1; 1H NMR (CDCl3) δ: 1.39-1.43 (t, 3H, CH3), 2.29-2.30 (2s, 
6H, CH3), 3.99 (s, 3H, OCH3), 4.42-4.48 (q, 2H, -CH2-), 6.20 (s, 1H, OH), 
7.00-7.03 and 7.43-7.81 (m, 3H, Ar), 8.28 (s, 1H, -CH=), 12.24 (s, 1H, 
NH) ppm; Mass m/z: 399 (M-1).
3f Ethyl 2-(2-cyano-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylamido)-
4,5-dimethyl thiophene-3-carboxylate: mp. 245-246°C; yield 80%; 
IR (KBr) υmax: 3464 (N-H str), 3168 (O-H str), 2984, 2930, 2850 (C-H 
str), 2204 (C≡N str), 1661 (ester C=O str), 1610 (amide C=O str), 
1561, 1503, 1456 (C=C str), 1246 (C-O str), 1158 and 1025 (-C-O-C 
asymmetric and symmetric) cm−1; 1H NMR (CDCl3) δ: 1.39-1.43 (t, 3H, 
CH3), 2.29- 2.30 (2s, 6H, CH3), 3.97 (s, 6H, OCH3), 4.42-4.48 (q, 2H, -CH2-), 
6.10 (s, 1H, OH), 7.26-7.34 (2s, 2H, Ar), 8.25 (s, 1H, -CH=), 12.24 (s, 1H, 
NH) ppm; Mass m/z: 453 (M + Na)+.
3g Ethyl 2-(2-cyano-3-(4-methoxyphenyl)acrylamido)-4,5-
dimethylthiophene-3-carboxylate: mp. 228-229°C; yield 90%; IR (KBr) 
υmax: 3425 (N-H str), 2976, 2930, 2852 (C-H str), 2212 (C≡N str), 1663 
(ester C=O str), 1590 (amide C=O str), 1560, 1515, 1429 (C=C str), 1262 
(C-O str), 1176 and 1019 (-C-O-C asymmetric and symmetric) cm−1; 1H 
NMR (CDCl3) δ: 1.39-1.43 (t, 3H, CH3), 2.29-2.30 (2s, 6H, CH3), 3.90 (s, 
3H, OCH3), 4.43-4.48 (q, 2H, -CH2-), 7.00-7.02 and 8.00-8.02 (2d, 4H, 
Ar), 8.32 (s, 1H, -CH=), 12.22 (s, 1H, NH) ppm; Mass m/z: 407 (M + Na)+.
3h Ethyl 2-(2-cyano-3-(3,4-dimethoxyphenyl)acrylamido)-4,5-
dimethylthiophene-3-carboxylate: mp. 231-232°C; yield 72%; IR (KBr) 
υmax: 3145 (N-H str), 2975, 2929, 2840 (C-H str), 2201 (C≡N str), 1666 
(ester C=O str), 1634 (amide C=O str) 1564, 1505, 1413 (C=C str), 1258 
(C-O str), 1144 and 1019 (-C-O-C asymmetric and symmetric) cm−1; 1H 
NMR (CDCl3) δ: δ 1.39 -1.43 (t, 3H, CH3), 2.29-2.30 (2s, 6H, CH3), 3.97 (s, 
6H, OCH3), 4.42-4.48 (q, 2H, -CH2-), 6.95-6.97 and 7.49-7.78 (m, 3H, Ar), 
8.29 (s, 1H, -CH=), 12.24 (s, 1H, NH) ppm; Mass m/z: 413 (M-1).
3i Ethyl 2-(2-cyano-3-(3,4,5-trimethoxyphenyl)acrylamido)-4,5-
dimethylthiophene-3-carboxylate: mp. 193-194°C; yield 80%; IR (KBr) 
υmax: 3167 (N-H str), 2982, 2937, 2841 (C-H str), 2204 (C≡N str), 1659 
(ester C=O str), 1601 (amide C=O str), 1559, 1532, 1429 (C=C str), 1248 
(C-O str), 1122 and 1019 (-C-O-C asymmetric and symmetric) cm−1; 
1H NMR (CDCl3) δ: 1.39-1.43 (t, 3H, CH3), 2.29-2.31 (d, 6H, CH3), 3.93-
3.96 (2s, 9H, OCH3), 4.42-4.48 (q, 2H, -CH2-), 7.26-7.30 (2s, 2H, Ar), 8.28 
(s, 1H, -CH=), 12.30 (s, 1H, NH) ppm; Mass m/z: 443 (M-1).
3j Ethyl 2-(2-cyano-3-(4-isopropylphenyl)acrylamido)-4,5-
dimethylthiophene-3-carboxylate: mp. 172-173°C; yield 78%; IR (KBr) 
υmax: 3156 (N-H str), 2962, 2928, 2871 (C-H str), 2212 (C≡N str), 1668 
(ester C=O str), 1588 (amide C=O str), 1558, 1529, 1405 (C=C str), 
1256 (C-O) cm−1; 1H NMR (CDCl3) δ: 1.27-1.29 (d, 6H, CH(CH3)2), 1.39-
1.43 (t, 3H, CH3), 2.29-2.30 (2s, 6H, CH3), 2.93-3.04 (sep, 1H, CH(CH3)2), 
4.43-4.48 (q, 2H, -CH2-), 7.37-7.39 and 7.94-7.96 (2d, 4H, Ar), 8.37 (s, 
1H, -CH=), 12.28 (s,1H, NH) ppm; Mass m/z: 419 (M + Na)+.
3k Ethyl 2-(2-cyano-3-(4-(dimethylamino)phenyl)acrylamido)-4,5-
dimethylthiophene-3-carboxylate: mp. 261-263°C; yield 78%; IR (KBr) 
υmax: 3154 (N-H str), 2986, 2917 (C-H str), 2202 (C≡N str), 1659 (ester 
C=O str), 1608 (amide C=O str), 1562, 1519, 1439 (C=C str), 1237 (C-O 
str) cm−1; 1H NMR (CDCl3) δ: 1.39-1.42 (t, 3H, CH3), 2.28-2.29 (2s, 6H, 
CH3), 3.11 (s, 6H, -N(CH3)2), 4.42-4.48 (q, 2H, -CH2-), 6.70-6.72 and 7.93-
7.95 (2d, 4H, Ar), 8.21 (s, 1H, -CH=), 12.07 (s, 1H, NH) ppm; Mass m/z: 
420 (M + Na)+.
In vitro antioxidant studies
The synthesized compounds were evaluated for their in vitro 
antioxidant properties in three different models, viz., reduction of 
1,1-diphenyl-2-pycrylhydrazyl (DPPH) free radical, scavenging of nitric 
oxide free radical, and ferric ion-induced lipid peroxidation using rat 
brain homogenate.
Reduction of DPPH free radical
DPPH is a nitrogen-centered free radical with an odd electron used to 
characterize the antioxidants. The delocalization of odd electron over 
the molecule as a whole makes it as a paramagnetic solid and when it is 
dissolved in absolute alcohol appears as a deep violet color solution with 
strong UV absorption at 517 nm. DPPH radical can accept electron or 
hydrogen radical to become stable diamagnetic molecule, 1,1-diphenyl-
2-picrylhydrazine (DPPH-H), which is colorless or pale yellow. This 
property makes it suitable for spectrophotometric studies [14]. 
A radical scavenging antioxidant reacts with DPPH stable free radical 
and converts to DPPH-H. The change in the absorbance produced in this 
reaction has been used to measure antioxidant properties.
Ethanolic solutions of test compounds at 100 µM concentration were 
added to 100 µM DPPH in 95% ethanol. The test tubes containing 
reaction mixture were shaken vigorously and allowed to stand at room 
temperature for 20 minutes. The absorbance was measured at 517 nm 
in a UV-visible spectrophotometer [15]. Control experiment was 
carried out with solvent only, and ascorbic acid was used as reference 
standard. All the measurements were performed in triplicate, and the 
mean of triplicate measurements was used to calculate the percentage 
reduction of DPPH by the following formula.
Percentage reduction of DPPH=[Control−Test]/Control×100
Assay of nitric oxide free radical scavenging
Sodium nitroprusside in aqueous solution at physiological pH 
spontaneously generates nitric oxide, which interacts with oxygen to 
produce nitrite ions. These nitrite ions can be estimated by diazotization 
reaction using Greiss reagent. Scavengers of nitric oxide compete with 
the oxygen leading to reduced production of nitric oxide [16].
Sodium nitroprusside (10 µM) in phosphate buffer pH 7.4 was incubated 
with 100 µM concentration of test compounds dissolved in alcohol for 
150 minutes at 25°C [17]. Then, 2 ml of incubation solution was removed 
and added to 2 ml of Griess reagent. The absorbance of chromophore 
formed during diazotization of nitrite with sulphanilamide and subsequent 
coupling with N-naphthylethylenediamine was read at 546 nm [18]. 
The control experiment was conducted in an identical manner without 
test compound but with an equal amount of solvent. The percentage of 
scavenging activity was calculated with the following formula:
Percentage of scavenging=[Control−Test]/Control×100
Ferric ion-induced lipid peroxidation
A 10% w/v rat brain homogenate was prepared in 0.15 M KCl and 
centrifuged at 800 g for 10 minutes, and the supernatant was used 
immediately for the study of in vitro lipid peroxidation [19]. The 
incubation mixture contained in a final volume of 1.5 ml, brain 
homogenate (0.5 ml), KCl (0.15 M), and ethanol (10 µl) or test 
compound dissolved in ethanol. Peroxidation was initiated by adding 
ferric chloride to give the final concentration 100 µM. After incubation 
for 20 minutes at 37°C, the reaction was stopped by adding 2 ml ice-cold 
0.25 M HCl containing 15% trichloroacetic acid, 0.38% thiobarbituric 
acid and 0.05% butylated hydroxytoluene. Following heating at 80°C 
for 15 minutes, samples were cooled and centrifuged at 1000 g for 
10 minutes. The absorbance of the supernatant solution was measured 
at 532 nm [20]. The percentage inhibition of thiobarbituric acid reactive 
substances formed by test compounds was calculated by comparing 
with vehicle only experiments [21].
Anti-inflammatory activity
The synthesized compounds with good antioxidant properties 
were pharmacologically evaluated for anti-inflammatory activity by 
carrageenan rat paw edema model.
Carrageenan-induced rat paw edema assay
Carrageenan-induced rat paw edema is a biphasic response. The 
first phase is mediated through the release of histamines, serotonin 
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and kinins, whereas the second phase is related to the release of 
prostaglandins and slow reacting substance which peak after 3 hrs 
of Carrageenan injection [22]. Carrageenan edema model has fairly 
high specificity and it is a standard experimental model of acute 
inflammation. This model has given consistent dose response curves 
for the major anti-inflammatory drugs such as diclofenac, aspirin, 
phenylbutazone, and indomethacin.
The male Wistar rats weighing 150-180 g were divided into groups, one 
group consisting of six served as control, while the other groups of five 
animals received the test compound or standard drug. The rats were 
dosed (100 mg/kg) orally with test compounds 1 hr before injection 
of 0.05 ml of 1% suspension of carrageenan into the subplantar region 
of the rat hind paw. Additional groups were similarly treated with 
100 mg/kg diclofenac to serve as positive control and 10 ml/kg 0.5% 
sodium carboxymethyl cellulose to serve as vehicle control. Initial paw 
volumes were measured by water displacement method immediately 
after carrageenan injection using digital plethysmograph. The paw 
volumes were again measured after 3 hrs. The average paw edema 
volumes for test group animals and positive control group were 
compared statistically with those of the vehicle control animals and 
expressed as percent edema inhibition [21].
RESULTS AND DISCUSSION
In our laboratory, a facile method has been developed for the 
synthesis of ethyl 2-(2-cyanoacetamido)-4,5-dimethylthiophene-3-
carboxylate from ethyl 2-amino-4,5-dimethylthiophene-3-carboxylate 
by cyanoacetylation with a versatile compound 1-cyanoacetyl-
3,5-dimethylpyrazole [7]. Ethyl 2-(2-cyanoacetamido)-4,5-
dimethylthiophene-3-carboxylate contains an active methylene 
group as nucleophilic site, hence a C=C double bond was generated 
by knoevenagel condensation reaction with various substituted 
benzaldehydes (2a-2k) in the presence of toluene containing catalytic 
amounts of piperidine and acetic acid. The reaction was simple 
and completed within 5-6 hrs to yield a series of ethyl 2-(2-cyano-
3-(substituted phenyl)acrylamido)-4,5-dimethylthiophene-3-
carbxoylates (3a-3k) almost in pure form. However, they were purified 
by recrystallization with alcohol. The compounds obtained in good 
yields ranging from 72% to 94%. The physical data of the synthesized 
compounds were given in Table 1. The structures of the synthesized 
compounds were confirmed by IR, 1H NMR, and mass spectra.
The IR spectra of final compounds showed an absorption band at 
3539-3145 cm-1 indicative of N-H stretching of an amide group. The 
absorption bands in the region of 2990-2840 cm-1 indicative of C-H 
stretching and in the region of 2214-2202 cm-1 corresponds to C≡N 
stretching. The absorption band corresponding to carbonyl group 
of ester and amide appeared in the region of 1667-1659 cm-1 and 
1634-1588 cm-1, respectively. The absorption peaks at 1565-1411 cm-1 
indicate the C=C stretching vibrations. The absorption band representing 
C-O stretching was appeared in the region of 1263-1230 cm-1. The 
compounds containing phenolic hydroxyl group showed an absorption 
band in the region of 3168-3110 cm-1 indicative of O-H stretching. The 
compounds with methoxy substitution exhibited absorption band 
in the region of 1176-1116 cm-1 and 1028-1019 cm-1 due to C-O-C 
asymmetric and symmetric stretching vibrations, respectively.
The NMR spectra of title compounds (3a-3k) showed triplet in 
the region of δ 1.33-1.43 due to methyl protons of ethyl ester and 
quartets in the region of δ 4.33-4.68 due to -CH2- protons of ethyl 
ester. The spectra also revealed the presence of two singlets in the 
region of δ 2.23-2.31 due to the protons of two methyl groups of 
4,5-dimethylthiophene ring. The spectra also exhibited multiplets in 
the region of δ 6.70-8.02 assignable to aromatic protons. The spectra 
of the compounds showed singlets in the region of δ 8.21-8.40 due to 
benzylidene protons and also singlets in the region of δ 12.07-12.35 
indicative of NH protons of amide group. The compounds containing 
methoxy group exhibited characteristic signals in the region of 
δ 3.90-3.97. The compound containing isopropyl group exhibited 
doublet and septet at δ 1.27-1.29 and δ 2.93-3.04, respectively. The 
methyl protons of dimethylamino derivative appeared as singlets in 
the region of δ 3.11. The disappearance of signal corresponding to 
active methylene protons of intermediate at δ 3.65 and appearance 
of benzylidene protons at δ 8.21-8.40 in all the NMR spectra of final 
compounds confirms the structures of title compounds.
The mass spectra of final compounds showed their characteristic 
molecular ion peak. Thus, the structures of the compounds were 
confirmed by IR, 1H NMR and mass spectral data.
In vitro antioxidant studies
The synthesized compounds, ethyl 2-(2-cyano-3-(substituted phenyl)
acrylamido)-4,5-dimethylthiophene-3-carbxoylates were evaluated for 
their in vitro antioxidant properties at 100 μM concentration in three 
different models, viz., reduction of DPPH free radical, scavenging of 
nitric oxide free radical and ferric ion-induced lipid peroxidation using 
rat brain homogenate. The activity data are presented in Table 2.
The study revealed that the compounds with phenolic hydroxyl 
group (3d, 3e and 3f) exhibited greater antioxidant activity in all 
the three models when compared with other evaluated compounds. 
Among which, the compound 3f, ethyl 2-(2-cyano-3-(4-hydroxy-3,5-
dimethoxyphenyl)acrylamido)-4,5-dimethylthiophene-3-carboxylate 
showed highest activity. The reason may be due to the presence of two 
methoxy groups, ortho to phenolic hydroxyl group making the molecule 
as sterically hindered phenol. This observation is in confirmation 
with the literature that steric hindrance of phenolic moiety is one of 
the factors governing antioxidant efficiency [23]. The conversion of 
phenolic hydroxyl group to methoxy group as in compounds 3g, 3h and 
3i resulted in reduction of antioxidant activity and indicated that the 
phenolic moiety is necessary to confer better antioxidant and radical 
scavenging properties. Further, the activity data revealed that the other 
evaluated compounds 3a, 3b, 3c, 3j, and 3k exhibited low to moderate 
antioxidant activity in all the three models.
Table 1: Physical data of ethyl 2-(2-cyano-3-(substituted phenyl) acrylamido)-4,5-dimethylthiophene-3-carboxylates
Compound R Molecular formula Molecular weight Melting point (°C) Yield (%) Rf*
3a H C19H18N2O3S 354 230-232 75 0.71
3b 4-Cl C19H17N2O3SCl 389 227-228 85 0.58
3c 4-CH3 C20H20N2O3S 368 232-235 94 0.66
3d 4-OH C19H18N2O4S 370 298-300 90 0.66
3e 4-OH, 3-OCH3 C20H20N2O5S 400 215-216 88 0.58
3f 4-OH, 3,5-di-OCH3 C21H22N2O6S 430 245-246 80 0.51
3g 4-OCH3 C20H20N2O4S 384 228-229 90 0.61
3h 3,4-di-OCH3 C21H22N2O5S 414 231-232 72 0.71
3i 3,4,5-tri-OCH3 C22H24N2O6S 444 193-194 80 0.83
3j 4-CH (CH3)2 C22H24N2O3S 396 172-173 78 0.91
3k 4-N (CH3)2 C21H23N3O3S 397 261-263 78 0.63
*Solvent system - 4:1 ratio of benzene and ethyl acetate
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Anti-inflammatory activity
The active compounds among the ethyl 2-(2-cyano-3-(substituted 
phenyl)acrylamido)-4,5-dimethylthiophene-3-carboxylates 
(Compounds 3d, 3e and 3f) were screened for anti-inflammatory 
activity by the carrageenan-induced rat paw edema assay at a dose of 
100 mg/kg, p.o. The activity data are presented in Table 3.
The results revealed that all the tested compounds possess good 
anti-inflammatory activity. Among the evaluated compounds, ethyl 
2-(2-cyano-3-(4-hydroxy-3-methoxyphenyl)acrylamido)-4,5-
dimethylthiophene-3-carboxylate (compound 3e) was found to be 
potent, and the inhibition of rat paw edema was 83.1%, comparable 
to the standard drug, Diclofenac (85.0%). The greater activity of this 
compound may be attributed to its physiological concentration and 
pharmacokinetic properties, which include absorption, distribution, 
metabolism, and excretion. Further, the compound 3f (4-hydroxy-3,5-
dimethoxy derivative) and the compound 3d (4-hydroxy derivative) 
were also found to have statistically significant edema inhibition 
values 75.4% and 70.2%, respectively. The better anti-inflammatory 
activity exhibited by the evaluated compounds may be due to 
the redox properties of phenolic hydroxyl group present in their 
structures.
CONCLUSION
An eco-friendly and easy method has been used to synthesize the title 
compounds. The method includes mild reaction conditions and easy 
work-up procedure for the isolation of products. The reaction led to the 
expected products with high yield and in all most all cases the products 
obtained in pure form.
The present research work revealed that the compounds of ethyl 
2-(2-cyano-3-(substituted phenyl)acrylamido)-4,5-dimethylthiophene-
3-carboxylate containing phenolic substitution showed greater 
antioxidant activity in all three different models. This clearly indicates 
that the phenolic moiety of these compounds confers antioxidant and 
radical scavenging properties. These active compounds also exhibited 
statistically significant anti-inflammatory activity in carrageenan 
rat paw edema model. The anti-inflammatory activity of phenolic 
compounds is most likely mediated, at least in part, by their antioxidant 
or redox mechanism. Hence, these compounds can be developed as 
useful therapeutic agents after establishing their safety pharmacology 
and toxicity profile.
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